General Information of the Compound
| Compound ID |
CP0867011
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-(3-(2-(4-(1,4'-bipiperidin-1'-yl)-2-methoxyphenylamino)pyrimidin-4-yl)-7-methoxyimidazo[1,2-a]pyridin-2-yl)-N-(2,6-difluorophenyl)-2-methoxybenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C43H44F2N8O4
|
||||||||||||||||||
| Molecular Weight |
774.873
|
||||||||||||||||||
| Canonical SMILES |
COc1ccn2c(-c3ccnc(Nc4ccc(N5CCC(N6CCCCC6)CC5)cc4OC)n3)c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C43H44F2N8O4/c1-55-30-17-23-53-38(26-30)49-39(27-10-13-36(56-2)31(24-27)42(54)50-40-32(44)8-7-9-33(40)45)41(53)35-14-18-46-43(48-35)47-34-12-11-29(25-37(34)57-3)52-21-15-28(16-22-52)51-19-5-4-6-20-51/h7-14,17-18,23-26,28H,4-6,15-16,19-22H2,1-3H3,(H,50,54)(H,46,47,48)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZIDYMRBSAWLZLI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor